Desh Rakshak Aushdhalaya Limited Stock Price Today (NSE: DESHRAK)
Fundamental Score
Desh Rakshak Aushdhalaya Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Desh Rakshak Aushdhalaya Limited share price today is ₹27.00, up +0.00% on NSE/BSE as of 30 March 2026. Desh Rakshak Aushdhalaya Limited (DESHRAK) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹21.08 (Cr). The 52-week high for DESHRAK share price is ₹95.14 and the 52-week low is ₹23.16. At a P/E ratio of 31.94x, DESHRAK is currently trading above its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 4.94% and a debt-to-equity ratio of 0.17.
Desh Rakshak Aushdhalaya Limited Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Desh Rakshak Aushdhalaya Limited Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Desh Rakshak Aushdhalaya Share Price: A Conservative Value Investor's Perspective
In the pharmaceutical sector, a defensive industry, consistent pricing power is crucial for long-term survival, particularly for smaller players. This analysis examines the financial health of Desh Rakshak Aushdhalaya share price, currently at ₹32.0, from a conservative value investor's perspective prioritizing capital safety. This report is part of an 80-parameter fundamental audit verified by Sweta Mishra.
The current Price-to-Earnings (PE) ratio of 31.94 suggests the market anticipates significant earnings growth. However, as a value investor, I look beyond speculative growth. A key metric is Return on Capital Employed (ROCE), which currently sits at 6.81%. This ROCE figure raises concerns. While acceptable for some industries, it is comparatively low within the pharmaceuticals sector, indicating the company may not be efficiently deploying its capital to generate profits. This impacts the company's potential economic moat – its ability to protect its market share and profitability over the long term. A higher ROCE would suggest a stronger moat and greater resilience.
Comparing Desh Rakshak Aushdhalaya Limited with its peers provides valuable context. While direct insight into management quality for Desh Rakshak Aushdhalaya is not readily available, considering a peer like
Mankind Pharma Ltd, known for its experienced management team and strong brand recognition, highlights the importance of effective leadership in navigating the complex pharmaceutical landscape. A company's ability to obtain regulatory approvals, manage supply chains, and maintain product quality heavily relies on competent management. A low ROCE can also reflect management inefficiencies needing attention.From a conservative investment standpoint, a company needs a robust and sustainable business model, particularly in the pharmaceutical sector where competition is fierce. A low ROCE, coupled with a high PE ratio, suggests a potential disconnect between market expectations and the company's current financial performance. Further investigation is warranted to ascertain the reasons behind the relatively low ROCE and its implications for long-term value creation and capital preservation. These are crucial factors to consider when assessing the overall risk-reward profile.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Desh Rakshak Aushdhalaya Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of DESHRAK across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Strong Operating Margins (19.58%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Conservative Debt Levels (D/E: 0.17)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Balanced Promoter Holding (50.07%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
7 factors identified
Below-Average Return on Equity (4.94%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (6.81%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Profit Decline Concern (-46.67%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-20.17%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Growth History (4.38% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Negative Free Cash Flow (₹-1.15 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Desh Rakshak Aushdhalaya Limited Financial Statements
Comprehensive financial data for Desh Rakshak Aushdhalaya Limited including income statement, balance sheet and cash flow
About DESHRAK (Desh Rakshak Aushdhalaya Limited)
Desh Rakshak Aushdhalaya Limited is a venerable institution deeply rooted in India's rich heritage of Ayurveda. For over a century, DESHRAK has been dedicated to crafting authentic... and effective remedies drawing upon time-tested formulations and natural ingredients. Nestled in the serene landscapes of Haridwar, the company meticulously blends ancient wisdom with modern manufacturing practices to produce a diverse portfolio of health and wellness solutions. From single-ingredient preparations to complex, multi-herb combinations, DESHRAK strives to offer holistic support for various health concerns, empowering individuals to embrace a balanced and healthy lifestyle. The company's commitment to quality and efficacy extends to every stage of production, from sourcing raw materials to rigorous testing, ensuring that each product reflects the purity and potency of nature's healing power. DESHRAK's product range encompasses a wide spectrum of Ayurvedic medicines designed to promote overall well-being and address specific health needs. These include traditional tablets, easily digestible capsules, and palatable syrups, alongside classic powders and concentrated liquid extracts. A particular strength of DESHRAK lies in its specialized Ayurvedic kits, thoughtfully curated collections of synergistic herbs designed to target particular health issues or support specific life stages. These kits, along with herbal dye solutions and community health worker (CHW) kits, exemplify the company's innovative approach to delivering comprehensive healthcare solutions, making the benefits of Ayurveda accessible to a broader population. The company prides itself on maintaining traditional methods and quality in the manufacturing of these products. With a steadfast dedication to its founding principles, DESHRAK not only serves the domestic market but also extends its reach globally through its export operations. This commitment enables DESHRAK to share the healing potential of Ayurveda with individuals worldwide, contributing to a growing appreciation for natural and holistic approaches to health. The legacy of DESHRAK is built upon a foundation of integrity, innovation, and a deep respect for the traditions of Ayurveda. As a trusted name in the pharmaceutical landscape, DESHRAK remains committed to providing high-quality, safe, and effective Ayurvedic solutions that empower individuals to live healthier, more fulfilling lives.
Company Details
Key Leadership
DESHRAK Share Price: Frequently Asked Questions
What is the current share price of Desh Rakshak Aushdhalaya Limited (DESHRAK)?
As of 30 Mar 2026, 11:00 am IST, Desh Rakshak Aushdhalaya Limited share price is ₹27.00. The DESHRAK stock has a market capitalisation of ₹21.08 (Cr) on NSE/BSE.
Is DESHRAK share price Overvalued or Undervalued?
DESHRAK share price is currently trading at a P/E ratio of 31.94x, compared to the industry average of 31.77x. Based on this relative valuation, the Desh Rakshak Aushdhalaya Limited stock appears to be Overvalued against its sector peers.
What is the 52-week high and low of DESHRAK share price?
The 52-week high of DESHRAK share price is ₹95.14 and the 52-week low is ₹23.16. These values are updated daily from NSE/BSE price data.
What factors affect the Desh Rakshak Aushdhalaya Limited share price?
Key factors influencing DESHRAK share price include quarterly earnings growth (Sales Growth: -20.17%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Desh Rakshak Aushdhalaya Limited a good stock for long-term investment?
Desh Rakshak Aushdhalaya Limited shows a 5-year Profit Growth of 9.86% and an ROE of 4.94%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.17 before investing in DESHRAK shares.
How does Desh Rakshak Aushdhalaya Limited compare with its industry peers?
Desh Rakshak Aushdhalaya Limited competes with major peers in the Pharmaceuticals. Investors should compare DESHRAK share price P/E of 31.94x and ROE of 4.94% against the industry averages to determine competitive standing.
What is the P/E ratio of DESHRAK and what does it mean?
DESHRAK share price has a P/E ratio of 31.94x compared to the industry average of 31.77x. Investors pay ₹32 for every ₹1 of annual earnings.
How is DESHRAK performing according to Bull Run's analysis?
DESHRAK has a Bull Run fundamental score of 28.2/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does DESHRAK belong to?
DESHRAK operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Desh Rakshak Aushdhalaya Limited share price.
What is Return on Equity (ROE) and why is it important for DESHRAK?
DESHRAK has an ROE of 4.94%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Desh Rakshak Aushdhalaya Limited generates profits from shareholders capital.
How is DESHRAK debt-to-equity ratio and what does it indicate?
DESHRAK has a debt-to-equity ratio of 0.17, which indicates conservative financing with low financial risk.
What is DESHRAK dividend yield and is it a good dividend stock?
DESHRAK offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Desh Rakshak Aushdhalaya Limited shares.
How has DESHRAK share price grown over the past 5 years?
DESHRAK has achieved 5-year growth rates of: Sales Growth 4.38%, Profit Growth 9.86%, and EPS Growth 9.86%.
What is the promoter holding in DESHRAK and why does it matter?
Promoters hold 50.07% of DESHRAK shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Desh Rakshak Aushdhalaya Limited.
What is DESHRAK market capitalisation category?
DESHRAK has a market capitalisation of ₹21 crores, placing it in the Small-cap category.
How volatile is DESHRAK stock?
DESHRAK has a beta of N/A. A beta > 1 suggests the Desh Rakshak Aushdhalaya Limited stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is DESHRAK operating profit margin trend?
DESHRAK has a 5-year average Operating Profit Margin (OPM) of 19.58%, indicating the company's operational efficiency.
How is DESHRAK quarterly performance?
Recent quarterly performance shows Desh Rakshak Aushdhalaya Limited YoY Sales Growth of -20.17% and YoY Profit Growth of -46.67%.
What is the institutional holding pattern in DESHRAK?
DESHRAK has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Desh Rakshak Aushdhalaya Limited stock.